arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

download Export Data

KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS

$28.52 ▼ -1.95 (-6.40%) at close

10 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

KESTRA MEDICAL TECHNOLOGIES, LTD. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7B

Dividend Yield —

Revenue Growth 59.9% ↘

Op. Margin -121.6% ↗

ROIC -52.0% ↗

FCF / Share $-0.69

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$30.97M

↑ +59.9% —

Net Income Profit after all expenses

$-44.09M

↓ -70.7% —

Operating Margin Operating profit as % of sales

-121.6%

↑ +11.5% 0th

FCF / Share Free cash flow per share

$-0.69

↓ -3.3% —

Long-Term Debt Long-term obligations

$72.50M

↑ +70.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Financial Health →

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Revenue Growth YoY (%)	59.9% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+649%)	66.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+727%)	62.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+684%)	53.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+567%)	51.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+544%)	—	—	—	—	—
EPS Growth YoY (%)	-50.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	57.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	51.2% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	46.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	55.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-70.7% Weak ↓ Weak Declining Year-over-year change in net income	25.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-58.8% Weak ↓ Weak Declining Year-over-year change in net income	-61.0% Weak Weak Year-over-year change in net income	-29.9% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-3.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	54.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	56.0% Excellent Excellent Year-over-year change in free cash flow	45.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Operating Margin (%) (%)	-121.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-911%)	-137.4% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1016%)	-141.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1044%)	-140.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1038%)	-149.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1094%)	-279.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1965%)	-136.5% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1010%)	-130.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-967%)	-144.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1061%)	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-142.3% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1286%)	-135.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1230%)	-139.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1260%)	-145.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1311%)	-133.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1211%)	-302.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2617%)	-142.5% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1288%)	-138.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1254%)	-155.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1396%)	—
FCF Margin (%) (%)	-131.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-99.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-114.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-113.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-177.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-182.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-146.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-153.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-192.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.23x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 2 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Return on Invested Capital (%)	-52.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-92.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-75.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-69.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-117.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-10.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-16.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Interest Coverage (x)	-34.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-22.32x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-39.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.54x Weak Weak Operating income divided by interest expense Optimal: > 5x	-15.11x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$3.94M	$-57.06M	$-249.06M	$-133.55M	$-159.73M	$-196.50M	$-54.35M	$-76.92M	$-99.97M	$34.29M
Debt / EBITDA (x)	-2.07x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.15x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.29x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.43x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.55x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.89x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 4 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Revenue per Share (USD)	$0.53	—	$0.44	$0.44	$0.38	—	$0.76	$0.74	$0.64	—
Basic EPS, GAAP (USD)	$-0.75	$-0.67	$-0.61	$-0.64	$-0.50	$-1.57	$-1.25	$-1.19	$-1.12	—
Free Cash Flow per Share (USD)	$-0.69	—	$-0.50	$-0.50	$-0.67	—	$-1.11	$-1.13	$-1.23	—
Basic Weighted Avg Shares (shares)	58.57M	—	55.85M	51.38M	51.30M	—	19.89M	19.89M	19.89M	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Working Capital (USD)	$178.00M	$171.99M	$271.13M	$159.66M	$188.44M	$217.35M	—	—	—	$-18.06M
LT Debt (USD)	$72.50M	$42.65M	$42.26M	$41.87M	$41.49M	$41.10M	—	—	—	$42.54M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2027 Jul 31, 2026 10-Q ↗	Q4 FY2026 Apr 30, 2026 10-K ↗	Q3 FY2026 Jan 31, 2026 10-Q ↗	Q2 FY2026 Oct 31, 2025 10-Q ↗	Q1 FY2026 Jul 31, 2025 10-Q ↗	Q4 FY2025 Apr 30, 2025 10-K ↗	Q3 FY2025 Jan 31, 2025 10-Q ↗	Q2 FY2025 Oct 31, 2024 10-Q ↗	Q1 FY2025 Jul 31, 2024 10-Q ↗	Q4 FY2024 Apr 30, 2024 10-K ↗
Sales/Revenue/Turnover (USD)	$30.97M	$28.64M	$24.55M	$22.57M	$19.37M	$17.23M	$15.09M	$14.71M	$12.78M	—
Depreciation Expense (USD)	$2.66M	$2.33M	$1.98M	$2.37M	$2.03M	$1.84M	$1.89M	$1.87M	$2.38M	—
Net Income, GAAP (USD)	$-44.09M	$-38.84M	$-34.17M	$-32.78M	$-25.83M	$-52.05M	$-21.51M	$-20.37M	$-19.88M	—
Operating Cash Flow (USD)	$-32.30M	$-18.72M	$-18.37M	$-18.34M	$-26.27M	$-24.06M	$-18.00M	$-18.06M	$-17.50M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 3 years · 10 quarters

KESTRA MEDICAL TECHNOLOGIES, LTD.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare KMTS with peers